PLOS ONE
Terman et al.%2C PLOS ONE.pdf
Adobe Acrobat document [2.0 MB]
Jenomic Rebuttal of Active Biotech Opposition
Jenomic Rebuttal of Active Biotech Oppos[...]
Adobe Acrobat document [2.6 MB]
JCR Cover Story
JCR Cover Story .pdf
Adobe Acrobat document [279.8 KB]
egc NO Superantigen
egc NO superantigen.pdf
Adobe Acrobat document [1.7 MB]
Download
Drug loaded SSRBCs
New file download
Interview with Joan Hamburg - WOR Radio
Joan - Dr. David .mp3
MP3 audio file [4.1 MB]

About Jenomic Research Institute

 

Jenomic is a biotech company devoted to developing novel drugs and drug vehicles for treatment of cancer. These efforts are supported by a raft of peer- reviewed publications and worldwide patents/patent applications.

 

The research team is led by David S. Terman, MD, an emeritus member of the American Society of Clinical Investigation (academia's physician-scientist honor society), former Professor  of Medicine, Microbiology and Immunology and Founding Director of Cancer Biology Program at Baylor College of Medicine. He is currently Adjunct Professor of Biochemistry and Molecular Biology at UAB in Birmingham. Dr. Terman is cited in Who's Who in America 2008-2013

As seen in the Monterey Herald

Cancer researcher David S. Terman stands among piles of research and patent paperwork in his home office in Pebble Beach on Friday. Terman runs the Jenomic Research Institute in Carmel. (DAVID ROYAL/The Herald)